Abaloparatide Appears Safe, Effective for Boosting BMD in Women 80 & Up
The FDA Approved Several New Rheumatology Drugs in 2017
Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada
Infliximab-abda Becomes 5th Biosimilar Approved in the U.S. & Abaloparatide Approved for Osteoporosis
U.S. & Europe Evaluate Abaloparatide Injection & Europe Approves Marketing Baricitinib for RA
